Article Versions Notes

Hao W, Wang L, Xu T, Jia G, Jiang Y, Qin C, Li X. Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine Drugs. 2024; 22(6):250. https://doi.org/10.3390/md22060250

Hao, Wanting, Leyan Wang, Tongqiang Xu, Geng Jia, Yuqi Jiang, Chong Qin, and Xiaoyang Li. 2024. "Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax" Marine Drugs 22, no. 6: 250. https://doi.org/10.3390/md22060250

Hao, W., Wang, L., Xu, T., Jia, G., Jiang, Y., Qin, C., & Li, X. (2024). Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine Drugs, 22(6), 250. https://doi.org/10.3390/md22060250